Search

everythinglearnresearchcommunity

for

Search:↓

EGCG may help treat alopecia areata by blocking certain immune responses and reducing specific harmful immune cells.

Machine learning can help identify biomarkers for personalized Pemphigus vulgaris treatment.

Melanogenesis-related proteins may trigger immune responses in alopecia areata patients.

More research is needed to understand the genetic causes of Alopecia areata to develop better treatments.

Alopecia areata is an autoimmune disease where T cells attack hair follicles.

HLA-DRB5 and other genes may be linked to alopecia universalis.

Certain genes on chromosomes 6, 10, 16, and 18 may increase the risk of alopecia areata.

Certain IL-18 gene variations may increase the risk of alopecia areata.

Genetic differences affect COVID-19 severity and treatment development.

The document concludes that Borrelia afzelii causes a skin condition in France, a gene is linked to hair loss in Caucasian women, and various genetic mutations affect skin diseases.

Certain genetic variations in IL18 may increase the risk of alopecia areata in Koreans.

Genetic discoveries are leading to new treatments for alopecia areata.

Vaccines are generally safe, but rare autoimmune reactions can occur, often influenced by genetics.

The document concludes that alopecia areata is an autoimmune disease without a definitive cure, but treatments like corticosteroids are commonly used.

Topical treatments led to hair regrowth in a man with linear morphea.

Alopecia areata involves immune response and gene changes affecting hair loss.

Alopecia areata may be treated by using EGCG to balance immune cells and reduce inflammation.

The conference presented findings on how vitamin D levels, genetic factors, and lifestyle choices like smoking and yoga affect various health conditions and diseases.

Genetic variants linked to ten skin diseases were found, showing both immune and non-immune factors play a role.

Certain gene variations increase the risk of alopecia areata in Koreans.

Insulin therapy helped a man with autoimmune issues regrow his hair.

Recent selection on immune response genes was identified across seven ethnicities.

Transplant success has improved with better immunosuppressive drugs and donor matching.

Restoring immune privilege in hair follicles could help treat certain types of hair loss.

A combined treatment with microneedling and vitamin D3 led to complete hair regrowth in a woman with stubborn patch alopecia areata.

Treg dysfunction is linked to various autoimmune skin diseases, and understanding Treg properties is key for new treatments.

An 11-year-old child with total hair loss may have a genetic autoimmune disease, and the outlook for hair regrowth is not good.

Lupus is a complex disease that requires personalized treatment because it varies greatly between individuals.

Female donor to male recipient sex mismatch and positive ACA-IgG are key risk factors for vitiligo and alopecia areata in chronic GvHD patients.

Vitiligo is a skin condition causing white spots, more common in women, often starts before age 20, and can affect mental health.